Lisa A. Damico‐Beyer

Pharmacokinetics of Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration: A Population Approach

Lu Xu, Tong Lu, Lisa Tuomi et al. · Investigative Ophthalmology & Visual Science · 2013 · 199 citations

Medicine, Pharmacokinetics, Pharmacology +15

A Guide to Rational Dosing of Monoclonal Antibodies

Shuang Bai, Karin Jorga, Denise Jin et al. · Clinical Pharmacokinetics · 2012 · 163 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Complement Inhibition in Cynomolgus Monkeys by Anti–Factor D Antigen-Binding Fragment for the Treatment of an Advanced Form of Dry Age-Related Macular Degeneration

Kelly M. Loyet, Jeremy Good, Teresa Davancaze et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 46 citations

Medicine, Ophthalmology, Pharmacology +17

Preclinical pharmacokinetics of MEHD7945A, a novel EGFR/HER3 dual-action antibody, and prediction of its human pharmacokinetics and efficacious clinical dose

Amrita V. Kamath, Dan Lu, Priyanka Gupta et al. · Cancer Chemotherapy and Pharmacology · 2011 · 40 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, onartuzumab (MetMAb), in patients with advanced solid tumors

Denise Jin, Stephen Eppler, Lisa A. Damico‐Beyer et al. · The Journal of Clinical Pharmacology · 2013 · 38 citations

Pharmacy, Oncology, Pharmacology +15